CA3051195A1 - Split inteins with exceptional splicing activity - Google Patents
Split inteins with exceptional splicing activity Download PDFInfo
- Publication number
- CA3051195A1 CA3051195A1 CA3051195A CA3051195A CA3051195A1 CA 3051195 A1 CA3051195 A1 CA 3051195A1 CA 3051195 A CA3051195 A CA 3051195A CA 3051195 A CA3051195 A CA 3051195A CA 3051195 A1 CA3051195 A1 CA 3051195A1
- Authority
- CA
- Canada
- Prior art keywords
- seq
- fragment
- intein
- split intein
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2851—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/90—Fusion polypeptide containing a motif for post-translational modification
- C07K2319/92—Fusion polypeptide containing a motif for post-translational modification containing an intein ("protein splicing")domain
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662288661P | 2016-01-29 | 2016-01-29 | |
| US62/288,661 | 2016-01-29 | ||
| PCT/US2017/015455 WO2017132580A2 (en) | 2016-01-29 | 2017-01-27 | Split inteins with exceptional splicing activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3051195A1 true CA3051195A1 (en) | 2017-08-03 |
Family
ID=59398921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3051195A Pending CA3051195A1 (en) | 2016-01-29 | 2017-01-27 | Split inteins with exceptional splicing activity |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11142550B2 (https=) |
| EP (2) | EP4234689A3 (https=) |
| JP (1) | JP7290305B2 (https=) |
| CN (1) | CN108884154A (https=) |
| AU (1) | AU2017211395B2 (https=) |
| CA (1) | CA3051195A1 (https=) |
| DK (1) | DK3408292T3 (https=) |
| ES (1) | ES2949163T3 (https=) |
| FI (1) | FI3408292T3 (https=) |
| HU (1) | HUE062276T2 (https=) |
| PL (1) | PL3408292T3 (https=) |
| PT (1) | PT3408292T (https=) |
| SI (1) | SI3408292T1 (https=) |
| WO (1) | WO2017132580A2 (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12529041B2 (en) | 2018-09-07 | 2026-01-20 | Beam Therapeutics Inc. | Compositions and methods for delivering a nucleobase editing system |
Families Citing this family (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6261500B2 (ja) | 2011-07-22 | 2018-01-17 | プレジデント アンド フェローズ オブ ハーバード カレッジ | ヌクレアーゼ切断特異性の評価および改善 |
| CA2909733C (en) | 2013-04-18 | 2023-10-17 | Fondazione Telethon | Effective delivery of large genes by dual aav vectors |
| US20150044192A1 (en) | 2013-08-09 | 2015-02-12 | President And Fellows Of Harvard College | Methods for identifying a target site of a cas9 nuclease |
| US9359599B2 (en) | 2013-08-22 | 2016-06-07 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
| US9388430B2 (en) | 2013-09-06 | 2016-07-12 | President And Fellows Of Harvard College | Cas9-recombinase fusion proteins and uses thereof |
| US9526784B2 (en) | 2013-09-06 | 2016-12-27 | President And Fellows Of Harvard College | Delivery system for functional nucleases |
| US9340799B2 (en) | 2013-09-06 | 2016-05-17 | President And Fellows Of Harvard College | MRNA-sensing switchable gRNAs |
| US20150165054A1 (en) | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Methods for correcting caspase-9 point mutations |
| WO2016022363A2 (en) | 2014-07-30 | 2016-02-11 | President And Fellows Of Harvard College | Cas9 proteins including ligand-dependent inteins |
| EP3322800A4 (en) | 2015-07-13 | 2019-05-01 | University of Utah Research Foundation | PROCESS FOR THE PRODUCTION OF RED BLOOD BODIES AND BLOOD PLATES IN VITRO AND USES THEREOF |
| JP7109784B2 (ja) | 2015-10-23 | 2022-08-01 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 遺伝子編集のための進化したＣａｓ９蛋白質 |
| ES2949163T3 (es) * | 2016-01-29 | 2023-09-26 | Univ Princeton | Inteínas divididas con actividad de corte y empalme excepcional |
| KR102547316B1 (ko) | 2016-08-03 | 2023-06-23 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 아데노신 핵염기 편집제 및 그의 용도 |
| US11661590B2 (en) | 2016-08-09 | 2023-05-30 | President And Fellows Of Harvard College | Programmable CAS9-recombinase fusion proteins and uses thereof |
| US11542509B2 (en) | 2016-08-24 | 2023-01-03 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
| EP3526320A1 (en) * | 2016-10-14 | 2019-08-21 | President and Fellows of Harvard College | Aav delivery of nucleobase editors |
| WO2018119359A1 (en) | 2016-12-23 | 2018-06-28 | President And Fellows Of Harvard College | Editing of ccr5 receptor gene to protect against hiv infection |
| EP3592853A1 (en) | 2017-03-09 | 2020-01-15 | President and Fellows of Harvard College | Suppression of pain by gene editing |
| JP2020510038A (ja) | 2017-03-09 | 2020-04-02 | プレジデント アンド フェローズ オブ ハーバード カレッジ | がんワクチン |
| JP2020510439A (ja) | 2017-03-10 | 2020-04-09 | プレジデント アンド フェローズ オブ ハーバード カレッジ | シトシンからグアニンへの塩基編集因子 |
| CA3057192A1 (en) | 2017-03-23 | 2018-09-27 | President And Fellows Of Harvard College | Nucleobase editors comprising nucleic acid programmable dna binding proteins |
| WO2018209320A1 (en) | 2017-05-12 | 2018-11-15 | President And Fellows Of Harvard College | Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation |
| WO2019023680A1 (en) | 2017-07-28 | 2019-01-31 | President And Fellows Of Harvard College | METHODS AND COMPOSITIONS FOR EVOLUTION OF BASIC EDITORS USING PHAGE-ASSISTED CONTINUOUS EVOLUTION (PACE) |
| EP3676376B1 (en) | 2017-08-30 | 2025-01-15 | President and Fellows of Harvard College | High efficiency base editors comprising gam |
| KR20250107288A (ko) | 2017-10-16 | 2025-07-11 | 더 브로드 인스티튜트, 인코퍼레이티드 | 아데노신 염기 편집제의 용도 |
| WO2019118949A1 (en) | 2017-12-15 | 2019-06-20 | The Broad Institute, Inc. | Systems and methods for predicting repair outcomes in genetic engineering |
| EP3797160A1 (en) | 2018-05-23 | 2021-03-31 | The Broad Institute Inc. | Base editors and uses thereof |
| US12522807B2 (en) | 2018-07-09 | 2026-01-13 | The Broad Institute, Inc. | RNA programmable epigenetic RNA modifiers and uses thereof |
| AU2019316094B2 (en) | 2018-08-03 | 2026-02-19 | Beam Therapeutics Inc. | Multi-effector nucleobase editors and methods of using same to modify a nucleic acid target sequence |
| US11530245B2 (en) * | 2018-08-31 | 2022-12-20 | Washington University | Split intein mediated polymerization and production of mussel foot adhesive protein materials |
| EP3850088A4 (en) | 2018-09-07 | 2023-07-19 | Beam Therapeutics, Inc. | Compositions and methods for improving base editing |
| AU2019360372B2 (en) * | 2018-10-15 | 2026-02-26 | Fondazione Telethon | Intein proteins and uses thereof |
| WO2020092453A1 (en) | 2018-10-29 | 2020-05-07 | The Broad Institute, Inc. | Nucleobase editors comprising geocas9 and uses thereof |
| US12351837B2 (en) | 2019-01-23 | 2025-07-08 | The Broad Institute, Inc. | Supernegatively charged proteins and uses thereof |
| LU101118B1 (en) * | 2019-02-06 | 2020-08-06 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Method for detecting a specific splice event of a gene of interest |
| WO2020168122A1 (en) | 2019-02-13 | 2020-08-20 | Beam Therapeutics Inc. | Modified immune cells having adenosine deaminase base editors for modifying a nucleobase in a target sequence |
| JP7657726B2 (ja) | 2019-03-19 | 2025-04-07 | ザ ブロード インスティテュート，インコーポレーテッド | 編集ヌクレオチド配列を編集するための方法および組成物 |
| US12473543B2 (en) | 2019-04-17 | 2025-11-18 | The Broad Institute, Inc. | Adenine base editors with reduced off-target effects |
| CN110714020B (zh) * | 2019-05-22 | 2021-08-03 | 北京理工大学 | 一种高效简便纯化蛋白的方法 |
| WO2021016075A1 (en) | 2019-07-19 | 2021-01-28 | Flagship Pioneering Innovations Vi, Llc | Recombinase compositions and methods of use |
| CA3152679A1 (en) * | 2019-08-28 | 2021-03-04 | The Trustees Of Princeton University | Atypical split inteins and uses thereof |
| US20220332757A1 (en) * | 2019-09-09 | 2022-10-20 | Wuhan Yzy Biopharma Co., Ltd. | Split intein and preparation method for recombinant polypeptide using the same |
| EP4034138A4 (en) | 2019-09-27 | 2024-07-31 | Beam Therapeutics, Inc. | COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIQUID CANCERS |
| KR20220070481A (ko) * | 2019-10-01 | 2022-05-31 | 유타대학연구재단 | 순환 종양 세포를 표적화하기 위한 혈소판 조작 방법 |
| US12435330B2 (en) | 2019-10-10 | 2025-10-07 | The Broad Institute, Inc. | Methods and compositions for prime editing RNA |
| GB201917046D0 (en) * | 2019-11-22 | 2020-01-08 | Ge Healthcare Bioprocess R&D Ab | Improved protein production |
| IL296024A (en) | 2020-03-04 | 2022-10-01 | Flagship Pioneering Innovations Vi Llc | Methods and compositions for modulating a genome |
| CN111235174A (zh) * | 2020-03-11 | 2020-06-05 | 梦芊科技知识产权有限公司 | 利用枯草芽孢杆菌和核酸内切酶制备人碱性成纤维细胞生长因子 |
| EP3885440A1 (en) * | 2020-03-26 | 2021-09-29 | Splicebio, S.L. | Split inteins and their uses |
| DE112021002672T5 (de) | 2020-05-08 | 2023-04-13 | President And Fellows Of Harvard College | Vefahren und zusammensetzungen zum gleichzeitigen editieren beider stränge einer doppelsträngigen nukleotid-zielsequenz |
| US20230227508A1 (en) | 2020-06-12 | 2023-07-20 | Massachusetts Institute Of Technology | Split intein-based selection for peptide binders |
| AU2021347359A1 (en) | 2020-09-25 | 2023-05-18 | Beam Therapeutics Inc. | Fratricide resistant modified immune cells and methods of using the same |
| CA3216901A1 (en) * | 2021-05-12 | 2022-11-17 | Cytiva Bioprocess R&D Ab | Improved protein purification |
| CN113735941B (zh) * | 2021-08-13 | 2024-01-30 | 江南大学 | 一种蛋白纯化方法及其应用 |
| KR102663243B1 (ko) * | 2021-08-30 | 2024-05-03 | 국립순천대학교산학협력단 | 트립신 특이적 형광 프로브 및 이의 용도 |
| JP2024533311A (ja) | 2021-09-08 | 2024-09-12 | フラッグシップ パイオニアリング イノベーションズ シックス，エルエルシー | ゲノムを調節するための方法及び組成物 |
| WO2023081714A1 (en) * | 2021-11-02 | 2023-05-11 | Cornell University | Intein systems and uses thereof |
| WO2023229029A1 (ja) * | 2022-05-26 | 2023-11-30 | 国立大学法人山形大学 | ヘテロダイマータンパク質の製造方法、ダイマータンパク質、モノマータンパク質、および標的反応性のヘテロダイマータンパク質のスクリーニング方法 |
| CA3267375A1 (en) * | 2022-09-26 | 2024-04-04 | Beam Therapeutics Inc. | SYNTHETIC POLYPEPTIDES AND THEIR USES |
| EP4612166A1 (en) * | 2022-11-01 | 2025-09-10 | Memorial Sloan-Kettering Cancer Center | Intein-based sorting system and modular chimeric polypeptides |
| WO2024170051A1 (en) * | 2023-02-13 | 2024-08-22 | Kutzner Christoph | Fusion polypeptides for manufacturing of cyclic peptides |
| KR20260040523A (ko) | 2023-06-11 | 2026-03-24 | 리제너론 파아마슈티컬스, 인크. | 환형화 항체 분자 |
| AU2024338787A1 (en) | 2023-09-04 | 2026-03-19 | Splicebio, Sl | Use of split intein for the treatment of scn1a associated disease |
| WO2025153705A1 (en) | 2024-01-18 | 2025-07-24 | Splicebio, Sl | Use of split intein for the treatment of myo7a-associated disease |
| WO2025194124A1 (en) | 2024-03-14 | 2025-09-18 | Tessera Therapeutics, Inc. | Modified st1cas9 guide nucleic acids |
| WO2026013288A1 (en) | 2024-07-12 | 2026-01-15 | Splicebio, Sl | Split intein for use in the treatment of cep290-associated disease |
| WO2026057767A1 (en) | 2024-09-13 | 2026-03-19 | Splicebio, Sl | Use of split intein for the treatment of abca3-associated disease |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2761006B1 (en) * | 2011-09-28 | 2016-12-14 | Zera Intein Protein Solutions, S.L. | Split inteins and uses thereof |
| DK3431497T3 (da) * | 2012-06-27 | 2022-10-10 | Univ Princeton | Spaltede inteiner, konjugater og anvendelser deraf |
| EP2943573A1 (en) * | 2013-01-11 | 2015-11-18 | The Texas A&M University System | Intein mediated purification of protein |
| ES2949163T3 (es) * | 2016-01-29 | 2023-09-26 | Univ Princeton | Inteínas divididas con actividad de corte y empalme excepcional |
-
2017
- 2017-01-27 ES ES17745022T patent/ES2949163T3/es active Active
- 2017-01-27 AU AU2017211395A patent/AU2017211395B2/en active Active
- 2017-01-27 CN CN201780021267.0A patent/CN108884154A/zh active Pending
- 2017-01-27 DK DK17745022.8T patent/DK3408292T3/da active
- 2017-01-27 CA CA3051195A patent/CA3051195A1/en active Pending
- 2017-01-27 HU HUE17745022A patent/HUE062276T2/hu unknown
- 2017-01-27 WO PCT/US2017/015455 patent/WO2017132580A2/en not_active Ceased
- 2017-01-27 SI SI201731373T patent/SI3408292T1/sl unknown
- 2017-01-27 PT PT177450228T patent/PT3408292T/pt unknown
- 2017-01-27 FI FIEP17745022.8T patent/FI3408292T3/fi active
- 2017-01-27 EP EP23168286.5A patent/EP4234689A3/en active Pending
- 2017-01-27 US US16/073,602 patent/US11142550B2/en active Active
- 2017-01-27 EP EP17745022.8A patent/EP3408292B1/en active Active
- 2017-01-27 PL PL17745022.8T patent/PL3408292T3/pl unknown
- 2017-01-27 JP JP2018539361A patent/JP7290305B2/ja active Active
-
2021
- 2021-06-30 US US17/363,698 patent/US12297472B2/en active Active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12529041B2 (en) | 2018-09-07 | 2026-01-20 | Beam Therapeutics Inc. | Compositions and methods for delivering a nucleobase editing system |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017132580A3 (en) | 2017-09-14 |
| ES2949163T3 (es) | 2023-09-26 |
| US20200055900A1 (en) | 2020-02-20 |
| EP3408292A4 (en) | 2019-09-18 |
| JP7290305B2 (ja) | 2023-06-13 |
| US11142550B2 (en) | 2021-10-12 |
| JP2019506163A (ja) | 2019-03-07 |
| PT3408292T (pt) | 2023-07-19 |
| SI3408292T1 (sl) | 2023-09-29 |
| HUE062276T2 (hu) | 2023-10-28 |
| DK3408292T3 (da) | 2023-06-12 |
| AU2017211395A1 (en) | 2018-09-06 |
| EP4234689A3 (en) | 2023-09-13 |
| AU2017211395B2 (en) | 2024-04-18 |
| PL3408292T3 (pl) | 2023-10-02 |
| EP3408292B1 (en) | 2023-04-26 |
| EP3408292A2 (en) | 2018-12-05 |
| CN108884154A (zh) | 2018-11-23 |
| WO2017132580A2 (en) | 2017-08-03 |
| US20210371467A1 (en) | 2021-12-02 |
| EP4234689A2 (en) | 2023-08-30 |
| US12297472B2 (en) | 2025-05-13 |
| FI3408292T3 (fi) | 2023-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12297472B2 (en) | Split inteins with exceptional splicing activity | |
| JP6591511B2 (ja) | スプリットインテイン、複合体およびそれらの使用 | |
| Johnson et al. | Towards the total chemical synthesis of integral membrane proteins: a general method for the synthesis of hydrophobic peptide-αthioester building blocks | |
| US5962267A (en) | Proinsulin derivative and process for producing human insulin | |
| Getz et al. | Protease-resistant peptide ligands from a knottin scaffold library | |
| US5648244A (en) | Production, purification, cleavage and use of fusion peptides | |
| Prabakaran et al. | Botulinum neurotoxin types B and E: purification, limited proteolysis by endoproteinase Glu-C and pepsin, and comparison of their identified cleaved sites relative to the three-dimensional structure of type A neurotoxin | |
| EP1220933B1 (en) | Purification of recombinant proteins fused to multiple epitopes | |
| US10000544B2 (en) | Process for production of insulin and insulin analogues | |
| CN102199214A (zh) | 制备蛋白质的方法 | |
| EP3530674B1 (en) | Polypeptide monomer, associated product formed of said polypeptide monomer having cell penetration function, norovirus component vaccine for subcutaneous, intradermal, percutaneous or intramuscular administration and having said associated product as effective component thereof, and method for producing said associated product | |
| Tran et al. | Evaluation of efficient non-reducing enzymatic and chemical ligation strategies for complex disulfide-rich peptides | |
| JP2021511785A (ja) | 組換えポリペプチド生産用ｎ末端融合パートナーおよびこれを用いた組換えポリペプチドの生産方法 | |
| HK40098890A (en) | Split inteins with exceptional splicing activity | |
| CN117801123B (zh) | 沃索利肽可溶性中间体、中间体制备方法及沃索利肽的制备方法 | |
| Osiro et al. | Cleaving the way for heterologous peptide production: An overview of cleavage strategies | |
| Hemu et al. | Peptide macrocyclization through amide-to-amide transpeptidation | |
| HK40001246B (en) | Split inteins with exceptional splicing activity | |
| HK40001246A (en) | Split inteins with exceptional splicing activity | |
| Shen et al. | Chemical synthesis of integral membrane proteins: methods and applications | |
| Hartmann et al. | Expression and purification of a nanostructure-forming peptide | |
| CN114181993B (zh) | 产生基于类泛素或泛素蛋白的生化工具的方法 | |
| CN114685679A (zh) | 谍捕手突变体及其制备方法与其在荧光蛋白质体系中的应用 | |
| Stevens et al. | Supporting Information for: Design of a Split Intein with Exceptional Protein Splicing Activity | |
| Kirkendoll et al. | Immobilized enzyme-assisted production of recombinant P113 peptide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220105 |
|
| D15 | Examination report completed |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT Effective date: 20241230 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 8TH ANNIV.) - STANDARD Year of fee payment: 8 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250117 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20250117 Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250117 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION Effective date: 20250429 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250430 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20250717 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20250717 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 9TH ANNIV.) - STANDARD Year of fee payment: 9 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20251210 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20251210 |